Tag: Cohere

Browse our exclusive articles!

Meta releases LLaMA 2, an open-source AI model for commercial use

Introducing LLaMA 2: Meta's groundbreaking open-source AI model for generative AI, offering enterprises a free and accessible alternative in the rapidly evolving LLM landscape.

Even ChatGPT’s AI surge couldn’t counteract decreased venture funding

Despite a drop in global venture funding, artificial intelligence (AI) companies still see successes, with major players and startups securing significant funding. However, the overall decline in venture funding raises concerns for the startup ecosystem's future.

OpenAI Considers Launching Marketplace for AI Models: Report

OpenAI may launch a marketplace for the sale of proprietary AI models, potentially giving access to its large language models for various use cases. The move could pose a challenge to customers and technology partners like Salesforce and Microsoft.

This Week In XR: AI Startups Cohere, Mistral, Synthesia Raise $463 Million, Medivis Enhances X-Ray Vision for Hololens

Get the latest scoop on tech news from Apple's Vision Pro XR headset to record-breaking investments in AI startups, all in one place.

Oracle Bets on Cohere as AI Rival to OpenAI

Oracle partners with Toronto-based AI startup, Cohere, to offer enterprise customers an alternative method to build generative AI apps using their own data. Cohere raised $270M in a series C funding round, with big tech names including NVIDIA, Salesforce Ventures, and SentinelOne. Oracle will be embedding Cohere's AI technology, and Cohere will use Oracle's cloud to train, build, and deploy its AI models. This partnership looks similar to Microsoft's investment in OpenAI, but Cohere is designed for enterprise customers, allowing them to use their own data to train their AI models without sharing it.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img